| Literature DB >> 28240232 |
Choo Hock Tan1, Kae Yi Tan2, Michelle Khai Khun Yap2, Nget Hong Tan2.
Abstract
Tropidolaemus wagleri (temple pit viper) is a medically important snake in Southeast Asia. It displays distinct sexual dimorphism and prey specificity, however its venomics and inter-sex venom variation have not been thoroughly investigated. Applying reverse-phase HPLC, we demonstrated that the venom profiles were not significantly affected by sex and geographical locality (Peninsular Malaya, insular Penang, insular Sumatra) of the snakes. Essentially, venoms of both sexes share comparable intravenous median lethal dose (LD50) (0.56-0.63 μg/g) and cause neurotoxic envenomation in mice. LCMS/MS identified six waglerin forms as the predominant lethal principles, comprising 38.2% of total venom proteins. Fourteen other toxin-protein families identified include phospholipase A2, serine proteinase, snaclec and metalloproteinase. In mice, HPLC fractions containing these proteins showed insignificant contribution to the overall venom lethality. Besides, the unique elution pattern of approximately 34.5% of non-lethal, low molecular mass proteins (3-5 kDa) on HPLC could be potential biomarker for this primitive crotalid species. Together, the study unveiled the venom proteome of T. wagleri that is atypical among many pit vipers as it comprises abundant neurotoxic peptides (waglerins) but little hemotoxic proteinases. The findings also revealed that the venom is relatively well conserved intraspecifically despite the drastic morphological differences between sexes.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28240232 PMCID: PMC5327433 DOI: 10.1038/srep43237
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1A pair of adult temple pit viper, Tropidolaemus wagleri from the Peninsular Malaya, Malaysia.
Upper panel: dorsal view; middle panel: lateral view; lower panel: anterior close up view. The snakes are arboreal and both sexes tend to intermingle most of the time as shown in this image. Sexual dimorphism is obvious, from body coloration to size i.e. length and girth of the body, where adult females typically exceed their male counterparts by multiple folds.
Figure 2Reverse-phase HPLC of venom samples on Lichrosphere® RP100 C18 column.
Venoms of Tropidolaemus wagleri: (A) Perak, female, n = 6; (B) Perak, male, n = 4; (C) Penang, female, n = 6; (D) Penang, male, n = 4; (E) Sumatra, female, n = 6. Venom of Tropidolaemus subannulatus: (G) Kalimantan, single female for comparison. Arrows indicate the single-peak fraction eluted between 38–42 min for male T. wagleri venom.
Figure 3Elution profile of Tropidolaemus wagleri crude venom on reverse-phase C18 HPLC (upper panel) and further separation by glycine SDS-PAGE (lower panel).
Two milligrams of T. wagleri venom (from 6 female specimens, Perak, Malaysia) were separated on a Lichrosphere® RP100 C18 column following the chromatographic conditions: 5% B for 10 min, 5–15% B for 20 min, followed by 15–45% B for 120 min and 45–70% B for 20 min. The chromatographic fractions were collected manually at 215 nm absorbance and the lyophilized fractions were further electrophoresed on glycine SDS-PAGE (18%, reducing condition). The protein bands were visualized by Coomassie blue staining. Low range protein marker was used as molecular mass standard (from 1.7 to 40 to kDa).
Assignment of Tropidolaemus wagleri (Perak, Malaysia) venom proteins by fractions of reverse-phase high performance liquid chromatography.
| Fraction | Database Accession | Protein subtypes | Relative abundance (% total venom proteins) |
|---|---|---|---|
| Fraction 6 | 10.94% | ||
| P24335 | Waglerin-3 | 10.94% | |
| Fraction 7 | 4.21% | ||
| P24335 | Waglerin-3 | 4.21% | |
| Fraction 8 | 17.13% | ||
| P58930 | Waglerin-4 | 17.13% | |
| Fraction 9 | 0.96% | ||
| P58930 | Waglerin-4 | 0.96% | |
| Fraction 10 | 4.10% | ||
| P58930 | Waglerin-4 | 4.10% | |
| Fraction 11 | 0.86% | ||
| P58930 | Waglerin-4 | 0.86% | |
| Fraction 12 | 5.77% | ||
| CL1260.contig1_NKM* | Acidic phospholipase A2 Tgc-E6 | 4.90% | |
| Q9W6W9 | Cytotoxin 4 N | 0.87% | |
| Fraction 13 | 3.16% | ||
| CL448.contig1_TW* | Serine protease 7 | 1.99% | |
| CL448.contig2_TW* | Plasminogen activator-like protein precursor | 0.38% | |
| Unigene24832_TW* | Beta-fibrinogenase mucrofibrase-3 | 0.78% | |
| Unigene14693_TW* | Galactose-binding lectin | 0.02% | |
| Fraction 14 | 0.47% | ||
| CL448.contig1_TW* | Serine protease 7 | 0.11% | |
| CL448.contig2_TW* | Plasminogen activator-like protein precursor | 0.20% | |
| Unigene14693_TW* | Galactose-binding lectin | 0.01% | |
| CL1654.contig2_TW* | Cysteine-rich secretory protein Og-CRPa | 0.00% | |
| F2Q6F3 | Cysteine-rich secretory protein Dr-CRPB | 0.00% | |
| CL1723.contig1_TW* | Basic phospholipase A2 homolog acutohaemolysin | 0.01% | |
| Unigene24832_TW* | Beta-fibrinogenase mucrofibrase-3 | 0.01% | |
| Unigene24831_TW* | Snake venom serine protease gussurobin | 0.07% | |
| Q71QI7 | Snake venom serine protease KN11 | 0.03% | |
| Q9YGI6 | Snake venom serine protease pallabin-2 | 0.01% | |
| Fraction 15 | |||
| CL1654.contig2_TW* | Cysteine-rich secretory protein Og-CRPa | 0.71% | |
| CL448.contig1_TW* | Serine protease 7 | 0.21% | |
| CL448.contig2_TW* | Plasminogen activator-like protein precursor | 0.37% | |
| CL1723.contig1_TW* | Basic phospholipase A2 homolog acutohaemolysin | 1.10% | |
| CL1260.contig2_NKM* | Lys-49 phospholipase A2 precursor | 1.26% | |
| Unigene24832_TW* | Beta-fibrinogenase mucrofibrase-3 | 1.24% | |
| Unigene14693_TW* | Galactose-binding lectin | 0.04% | |
| Fraction 16 | 2.79% | ||
| Unigene330_TW* | Metalloproteinase isoform 1 | 0.57% | |
| CL3502.contig1_TW* | Intestinal-type alkaline phosphatase 1-like TW1 | 0.16% | |
| Unigene24659_TW* | Snake venom 5′-nucleotidase | 0.25% | |
| Unigene24655_TW* | Snake venom 5′-nucleotidase | 0.26% | |
| Unigene19683_TW* | GPX3 | 0.58% | |
| Unigene14693_TW* | Galactose-binding lectin | 0.36% | |
| CL448.contig1_TW* | Serine protease 7 | 0.07% | |
| Unigene22180_TW* | L-amino acid oxidase | 0.05% | |
| CL1504.contig1_TW* | Zinc metalloproteinase-disintegrin HV1 | 0.04% | |
| Unigene18_TW* | Agglucetin subunit alpha-2 | 0.11% | |
| Unigene23090_TW* | C-type lectin 9 | 0.30% | |
| CL1723.contig1_TW* | Basic phospholipase A2 homolog acutohaemolysin | 0.02% | |
| CL2565.contig1_TW* | ADP-ribosyl cyclase 1 | 0.03% | |
| Fraction 17 | 7.61% | ||
| Unigene22180_TW* | L-amino acid oxidase | 1.48% | |
| CL2548.contig1_TW* | Phosphodiesterase 1 | 0.28% | |
| J3SEZ3 | Venom phosphodiesterase 1 | 0.36% | |
| Unigene21602_TW* | Phosphodiesterase 1 | 0.24% | |
| CL1504.contig1_TW* | Zinc metalloproteinase-disintegrin HV1 | 0.83% | |
| Unigene22208_TW* | Gastric intrinsic factor-like | 0.47% | |
| Unigene370_NSM* | Cobra venom factor | 0.12% | |
| CL4560.contig1_NSM* | Cobra venom factor | 0.11% | |
| Q91132 | Cobra venom factor | 0.16% | |
| Unigene19683_TW* | GPX3 | 0.58% | |
| Unigene22208_TW* | Gastric intrinsic factor-like | 0.52% | |
| Unigene24655_TW* | Snake venom 5′-nucleotidase | 0.34% | |
| Unigene10279_CRM* | Snake venom 5′-nucleotidase | 0.30% | |
| Unigene24659_TW* | Snake venom 5′-nucleotidase | 0.29% | |
| Unigene23090_TW* | C-type lectin 9 | 0.90% | |
| Unigene18_TW* | Agglucetin subunit alpha-2 | 0.27% | |
| F8S101 | Phospholipase B | 0.27% | |
| U3TBU1 | Hyaluronidase | 0.11% | |
| Fraction 18 | 2.57% | ||
| CL4560.contig1_NSM* | Cobra venom factor | 0.04% | |
| Q91132 | Cobra venom factor | 0.04% | |
| Unigene22180_TW* | L-amino acid oxidase | 0.18% | |
| CL1504.contig1_TW* | Zinc metalloproteinase-disintegrin HV1 | 0.28% | |
| Unigene23090_TW* | C-type lectin 9 | 0.41% | |
| Unigene19683_TW* | GPX3 | 0.08% | |
| Unigene24659_TW* | Snake venom 5′-nucleotidase | 0.06% | |
| Unigene24655_TW* | Snake venom 5′-nucleotidase | 0.05% | |
| Unigene22208_TW* | Gastric intrinsic factor-like | 0.05% | |
| CL3071.contig1_TW* | Aminopeptidase N TW1 | 0.05% | |
| Unigene21602_TW* | Phosphodiesterase 1 | 0.07% | |
| CL2548.contig1_TW* | Phosphodiesterase 1 | 0.05% | |
| Unigene18_TW* | Agglucetin subunit alpha-2 | 1.10% | |
| Unigene20823_TW* | Phospholipase B | 0.04% | |
| A5HUI5 | Aminopeptidase A | 0.02% | |
| CL2256.contig1_TW* | Phospholipase A2 inhibitor beta TW1 | 0.04% |
*Indicate venom proteins identified based on tryptic peptides matched to sequences from in-house transcript-database. Mass spectrometric data and peptide sequences are available in Supplementary File S1.
Protein family subtypes and relative abundance (%) in the venoms of Tropidolaemus wagleri.
| Protein family/Protein subtype | Accession No. | Relative abundance (%) |
|---|---|---|
| Waglerin-3 | P24335 | 15.15 |
| Waglerin-4 | P58930 | 23.04 |
| Acidic phospholipase A2 Tgc-E6 | CL1260.contig1_NKM* | 4.90 |
| Basic phospholipase A2 homolog acutohaemolysin | CL1723.contig1_TW* | 1.13 |
| Phospholipase A2 | CL1260.contig2_NKM* | 1.26 |
| Serine protease 7 | CL448.contig1_TW* | 2.37 |
| Plasminogen activator-like protein precursor | CL448.contig2_TW* | 0.95 |
| Beta-fibrinogenase mucrofibrase-3 | Unigene24832_TW* | 2.03 |
| Snake venom serine protease gussurobin | Unigene24831_TW* | 0.07 |
| Snake venom serine protease KN11 | Q71QI7 | 0.03 |
| Snake venom serine protease pallabin-2 | Q9YGI6 | 0.01 |
| Galactose-binding lectin | Unigene14693_TW* | 0.42 |
| C-type lectin 9 | Unigene23090_TW* | 1.60 |
| Agglucetin subunit alpha-2 | Unigene18_TW* | 1.47 |
| Metalloproteinase isoform 1 | Unigene330_TW* | 0.57 |
| Zinc metalloproteinase-disintegrin HV1 | CL1504.contig1_TW* | 1.15 |
| L-amino acid oxidase | Unigene22180_TW* | 1.71 |
| Snake venom 5′-nucleotidase | Unigene24659_TW* | 0.60 |
| Snake venom 5′-nucleotidase | Unigene24655_TW* | 0.65 |
| Snake venom 5′-nucleotidase | Unigene10279_CRM* | 0.30 |
| Phosphodiesterase 1 | CL2548.contig1_TW* | 0.33 |
| Phosphodiesterase 1 | Unigene21602_TW* | 0.30 |
| Venom phosphodiesterase 1 | J3SEZ3 | 0.36 |
| Cytotoxin 4 N | Q9W6W9 | 0.87 |
| Cysteine-rich secretory protein Og-CRPa | CL1654.contig2_TW* | 0.71 |
| Cysteine-rich secretory protein Dr-CRPB | F2Q6F3 | 0.00 |
| Cobra venom factor | Unigene370_NSM* | 0.12 |
| Cobra venom factor | CL4560.contig1_NSM* | 0.14 |
| Cobra venom factor | Q91132 | 0.21 |
| Phospholipase B | Unigene20823_TW* | 0.31 |
| Hyaluronidase | U3TBU1 | 0.11 |
| Aminopeptidase N TW1 | CL3071.contig1_TW* | 0.05 |
| Aminopeptidase A | A5HUI5 | 0.02 |
| Phospholipase A2 inhibitor beta TW1 | CL2256.contig1_TW* | 0.04 |
| GPX3 | Unigene19683_TW* | 1.23 |
| Gastric intrinsic factor-like | Unigene22208_TW* | 1.04 |
| Intestinal-type alkaline phosphatase 1-like TW1 | CL3502.contig1_TW* | 0.16 |
| ADP-ribosyl cyclase 1 | CL2565.contig1_TW* | 0.03 |
| — | ||
*Indicate venom proteins identified based on tryptic peptides matched to sequences from in-house transcript-database. All peptide sequences are available in Supplementary File S1.
Figure 4Venom proteome of Tropidolaemus wagleri (Perak, Malaysia) venom.
Percentage indicates relative abundance of a protein class with respect to total venom proteins.
Median lethal doses (LD50) of Tropidolaemus wagleri venom from male and female specimens (Malaysia) in mice and frogs (95% C.I. in parenthesis).
| LD50 (μg/g) in mice via intravenous route | LD50 (μg/g) in frogs via intra-lymphatic route | |
|---|---|---|
| Female | 0.56 (0.37–0.84) | 38.31 (29.99–48.94) |
| Male | 0.63 (0.59–0.66) | 41.77 (32.78–53.23) |
Intravenous median lethal doses (i.v. LD50) of the protein fractions of Tropidolaemus wagleri venom (female specimens, Perak, Malaysia) in mice.
| Protein Fraction | |
|---|---|
| F1 | >4 |
| F2 | >1 |
| F3 | >1 |
| F4 | >4 |
| F5 | >2 |
| F6 | 0.063 (0.059–0.066) |
| F8 | 0.20 (0.16–0.25) |
| F12 | >4 |
| F13 | >4 |
| F14-15 (pooled) | >4 |
| F16 | >2 |
| F17-18 (pooled) | >2 |
The protein components were resolved by the reverse-phase high performance liquid chromatography.